Pediatric hospital medicine and children with medical complexity: past, present, and future

Tamara D Simon1, Sanjay Mahant, Eyal Cohen

  • 1Department of Pediatrics, Division of Hospital Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington, USA.

Insights

Complex care addresses the holistic needs of children with medical complexity (CMC), requiring specialized coordination. Pediatric hospitalists are leading advancements in clinical care, research, and education for these children.

Area of Science:

  • Pediatric Hospital Medicine
  • Complex Care Medicine

Background:

  • Children with medical complexity (CMC) share common challenges: intensive service needs, technology dependence, polypharmacy, and high healthcare utilization.
  • Effective management requires holistic care, integrating general pediatrics with expertise in care coordination and interdisciplinary communication.

Purpose of the Study:

  • To review the evolution and future directions of complex care for CMC within pediatric hospital medicine.
  • To examine complex care across practice management, clinical care, research, education, and quality improvement domains.

Main Methods:

  • This section is a review article, synthesizing existing literature and expert perspectives.
  • Focuses on the role of pediatric hospitalists in the field of complex care.

Main Results:

  • Complex care has emerged as a distinct field, with pediatric hospitalists playing a central role.
  • Pediatric hospitalists are actively involved in clinical practice, research, and education for CMC.

Conclusions:

  • Pediatric hospital medicine is well-positioned to lead the advancement of complex care for CMC.
  • Future efforts should focus on enhancing care coordination, research, and educational strategies for this population.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...